New insights into photodynamic therapy treatment through the use of 3D Monte Carlo radiation transfer modelling by Campbell, C. Louise et al.
New insights into photodynamic therapy treatment through
the use of 3D Monte Carlo radiation transfer modelling.
C. Louise Campbella, Kenneth Wood a, C. Tom A. Browna and Harry Moseleyb
aSUPA, School of Physics and Astronomy, University of St Andrews, UK;
bPhotobiology Unit, Ninewells Hospital and Medical School, University of Dundee, UK
ABSTRACT
Photodynamic therapy (PDT) has been theoretically investigated using a Monte Carlo radiation transfer (MCRT)
model. By including complex three dimensional (3D) tumour models a more appropriate representation of the
treatment was achieved. The 3D clustered tumour model was compared to a smooth model, resulting in a
significantly deeper penetration associated with the clustered model. The results from the work presented here
indicates that light might penetrate deeper than suggested by 2D or simple layered models.
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1. INTRODUCTION
Photodynamic therapy (PDT) relies on the interaction between light, a photosensitive chemical and molecular
oxygen to kill targeted cells. This non-invasive treatment method provides an efficient way of topically treating
skin lesions such as non-melanoma skin cancer (NMSC) and precancerous lesions including Basal Cell Carcinoma
(BCC), Aktinic Keratosis (AK) and Bowen’s disease (BD). Through selective accumulation of the photosensitiser
in tumour cells, the treatment achieves an interaction where healthy tissue surrounding the lesion is largely
unaffected. For topical PDT, a prodrug in the form of a cream is topically applied to the lesion prior to the
irradiation of light. The cream contains either 5-aminolaevulinic acid (ALA) or methyl aminolevulinate (MAL),
which is converted within the tumour cells into the photosensitive molecules Protoporphyrin IX (PpIX).1,2
The PpIX absorbes light over a wide range of wavelengths. It is common however to target the small
absorption peak at around 630 nm to achieve deep penetration of the excitation radiation. Recent studies have
shown that alternative light sources such as daylight, can achieve sufficient treatment depths for eradicating
superficial skin lesions such as AKs.3,4 By utilising the whole absorption spectrum of the photosensitiser a
lower irradiance is required to achieve the same absorption. Even though this results in a slightly more shallow
treatment due to the dominating absorbing features of PpIX in the blue wavelength range (figure 1 c) many
efficient results have been reported.5–9 Daylight has been shown to be associated with a lower experienced pain10
and the preferred choice of treatment by the majority of patients.3 In the work presented here we compare
daylight PDT to conventional PDT where the artificial light source Aktilite is adopted (Akitlite, Photocure
ASA, Norway11).
To further investigate the light interaction with skin tissue during the treatment, theoretical models are
commonly adopted. Monte Carlo radiation transfer (MCRT) modelling is the gold standard when simulating
light transport through skin tissue. MCRT provides a flexible method which generates accurate information of
the light distribution, scattering and absorption events within the skin tissue during illumination. The majority
of MCRT models simulating PDT assume uniform distributions of skin tissue.12 Some models introduce layers of
different tissue types and/or tumours represented by geometric shapes. However, within the confined areas, the
distribution of the tissue type is uniform. Here a 3D MCRT model is introduced where the tumour is represented
by a hierarchical structure, regrouping the density of the tumour into clusters. This allows for the 3D features
of the model to be explored and provides important information about the relevance of including a 3D system.
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Figure 1: Figure showing the spectra included in the theoretical model. a) Spectral irradiance of the two daylight
components. Direct daylight (solid) has a defined directionality while the diffuse daylight (dashed) is assumed
to not have a defined directionality.13 b) Spectral irradiance of the conventional light source (Aktilite) adopted
in the model. c) Absorption spectrum of the photosensitiser PpIX corresponding to the smooth initial number
density of PpIX molecules equal to 7.84× 1013 cm−3. However the absorption properties vary depending on the
concentration of the PpIX within the tumour tissue.14,15
2. METHODS
The radiative transfer equation (RTE) describes the propagation of photons through any medium.16 Due to the
difficulty in solving the equation, several approximations have been developed. MCRT is a numerical technique
which simulates the light distribution through a highly scattering media by utilising the probabilistic nature of
the photon interactions. This technique accurately describes the propagation of light through skin tissue and
has several times been used to simulated light therapies such as PDT.17,18 The code that is presented here has
been developed from a publicly available code has been thoroughly validated.4,19
2.1 Monte Carlo radiation transfer
The MCRT code tracks energy packets (hereafter referred to as photons) as they propagate through their
propagation through a 3D Cartesian grid containing voxels. By allocating appropriate optical properties to each
voxel, the scattering and absorption events are accurately represented. These events are recorded by conributing
to counters containing information about the energy deposition and light distribution. The photons are tracked
through the grid until they are either absorbed or scattered out of the simulated region. By repeating the process
for multiple photons the results approach the true representation. The optical properties within each voxel can
differ from adjacent voxels, which allows for complicated 3D structures to be included. This was utilised in our
work to include complex 3D tumour structures that were subsequently compared to models where the tumour
was assumed to have a uniform density.
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Figure 2: Figure demonstrating the Cartesian grid that was simulated to represent the skin tissue. Within the
cube a cylindrical tumour with a diameter of 6 mm was included. The length of each side of the cube was set to
be 10 mm. The density of the tumour model was assumed to be uniform throughout the tumour for the smooth
model. For the fractal model the density was rearranged within the cylinder with the average density throughout
the cylinder was the same.
2.2 Code set up
The grid system was assumed to be uniformly illuminated from above (figure 2). The grid contained 101×101×101
voxels with the dimensions 10 mm× 10 mm× 10 mm. The optical properties that were adopted are displayed in
figure 3. These determine the probability of a scattering or absorption event occurring at an interaction event.
The Heyney-Greenstein phase function20 was adopted to describe the scattering angular distribution where the
anisotropy factor was assumed to follow the wavelength dependency, g = 0.62+λ×0.29×10−3 (with λ in nm).21
The refractive index was assumed to be uniform for all tissue types (n=1.38) and the refraction and reflection
at the upper boundary was considered using Snell’s law and Fresnel reflectance.
Repeated boundaries were adopted to represent a semi-infinate tissue slab. 3D wavelength dependent pho-
tobleaching depending on both fluence rate and initial concentration of PpIX was included to consider the
destruction of PpIX during the illumination.4 It was assumed that there was an unlimited oxygen supply and
the PpIX was assumed to only be present within the tumour areas.
The fluence rate was generated for three wavelengths, 405, 540 and 630 nm to compare different parts of
the spectra. In addition the photodynamic dose (PDD) was generated for both conventional and daylight PDT
where the PDD is defined as the number of absorbed photons by the photosensitiser per unit volume.25 The
PDD is assumed to be proportional to the number of produced singlet oxygen molecules and a toxic threshold can
therefore be considered. This allows for an estimation of the efficient treatment depth and means of comparing
different light sources and treatment conditions.26 For illustrative purposes a threshold of 8.6×1017 photons cm−3
was adopted to enable the comparison between the different treatment modalities considered.17 The effect of
including a fractal clustered model (section 2.4) and a smooth model was compared for both daylight as well as
conventional PDT.
The fluorescence generated by 405 nm excitation was simulated by assuming that each absorption by the
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Figure 3: Figure showing the optical properties implemented within the theoretical model. Both the absorption
and scattering properties of the healthy and diseased tissue are included within the figure. The optical properties
were generated from algorithms presented by Yudovsky et al22,23 as well as from data extracted from Salomatina
et al24 using the approach developed by Jacques et al.17
PpIX resulted in a fluorescence photon. The fluorescence photon was assumed to be isotropically reemitted from
the absorption location at a wavelength sampled from the spectra shown in figure 4. All fluorescence photons
escaping from the surface of the grid was recorded, generating a simulation of the expected wide field fluorescence
image.
2.3 Light sources
The spectral distribution of the different light sources investigated are displayed in figure 1. The conventional
treatment methods assumed a vertical illumination with the irradiance of 82 mW cm−2. For daylight PDT both
the direct and diffuse component of the light source had to be considered. To simulate a clear day it was assumed
that 80 % of the light was direct while 20 % was assumed to be diffuse light. The direct light was assumed to
have a defined directionality and illuminate the surface of the skin at an angle of 30 degrees (from the normal)
and the diffuse component was assumed to not have any defined directionality. This was considered by randomly
allocating a direction of illumination for each photon, resulting in a uniformly diffuse illumination of the surface
of the skin. It is possible to simulate different weather conditions by changing the ration between the direct
and tissue component however here we only considered the clear case. The irradiance of the clear daylight case
was determined to be 41 mW cm−2. These values for the daylight are equivalent to those observed at noon in
summer at a latitude of 56 degrees North.4
The wavelength of the simulated photon was randomly determined from the light spectra such that the
probability distribution function of the illuminating spectra is reproduced. Hence the allocated wavelength
depends on the spectral distribution of the light source (figure 1).
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Figure 4: Figure showing the fluorescent spectra generating by the PpIX.
2.4 Tumour models
The original model consisted of a symmetric grid system containing a cylindrical tumour in the centre and has
been adopted in our previous work (figure 2).4 Within the cylindrical tumour, the density was assumed to have
a uniform distribution. This smooth model was compared to a fractal model where the density of the tumour
tissue was rearranged such that the average density throughout the tumour region was the same as the smooth
model. The motivation for using a clustered model is to demonstrate what is believed to be a more complex and
potentially a more realistic model of a tumour structure. Through histopathological images27 of skin lesions, the
clustered model appears to be an appropriate initial step into modelling different tumour structures.
The 3D clustered structure was determined using the algorithm presented by Elmegreen (1997).28 Four levels
of the algorithm is adopted. At the first level, 128 points are determined within the 3D coordinate system. At
the next level 128 points were cast around each individual point from the previous level. This was then repeated
for a total of four levels generating a fractal model. The distance of the subsequent level from the previous level
reduces with the increased hierarchical level. For a more details description of the complex clustered model,
see Wood et al (2005).29 The algorithm restructures the density and for the model presented here 70 % of the
tumour was assumed to be within the clustered features while the remaining 30 % was defined as the smooth
component which comprises the remaining area around the different clusters. Figure 5 shows both the surface
of the clustered model (a) as well as a slice of the tumour in the vertical plane (b).
The initial distribution of PpIX was assumed to be distributed identical to that of the tumour tissue. Hence
for the smooth model the initial distribution of PpIX was assumed to be uniform within the cylindrical tumour
while for the fractal case the PpIX was assumed to have an initial distribution identical to the fractal model.
For the purpose of this work the PpIX was assumed to not be present within the healthy tissue surrounding
the tumour. It was assumed that the tissue surrounding the tumour was of a single tissue type (dermis) and of
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Figure 5: b) Figure showing a slice of the tumour, where the density was regrouped within the cylindrical
tumour. a) Figure showing the top of the grid, displaying the surface of the developed tumour structure. 70 %
of the density was regrouped into the clustered features while 30 % of the total tumour content was smoothly
distributed throughout the cylinder. It was assumed that the photosensitiser PpIX is only contained within the
tumour tissue.
smooth uniform density.
3. RESULTS
The penetration of light is highly wavelength dependent and this is demonstrated in figure 6 where the fluence
rate for three different wavelengths is displayed. The figure demonstrates the average over the whole cylindrical
area. Both the fractal and the smooth models are compared for the three wavelengths and it is clear that there
is a large difference between the two different models. The fractal model results in deeper penetration due to the
clusters generating gaps of lower density. The fluence rate also demonstrates how the light penetrated deeper
for the longer wavelength (630 nm) which is a wavelength typical used for conventional PDT.
Figure 7 shows the PDD for daylight (during clear conditions) as well as conventional PDT. The figure
demonstrates the accumulated PDD after a delivered light dose of 75 J cm−2 which results in different treatment
time for the different light conditions. This is a typical light dose delivered for conventional PDT treatments and
therefore the light dose compared. Both the fractal model and the smooth model are compared demonstrating
the significantly deeper penetration arising from the fractal model. The horizontal line in figure 7 represents the
toxic threshold. The results indicate an additional 0.5 mm gained in treatment depth, by considering a complex
3D tumour structure.
The fluorescence image generated by the simulation is shown in figure 8. This differs from the density image
in figure 5 since it considers fluorescence light from below the surface of the tumour.
4. DISCUSSION
The introduction of a clustered 3D tumour model gives a more reasonable representation of the physical situation.
This is the first time 3D features of light distribution of skin tissue have been explored. Previous symmetric
shapes does not introduce the properties demonstrated here. By regrouping the tumour and PpIX density the
light is allowed to penetrate deeper due to the added areas of reduced density. There is also an overall higher
accumulated absorption at the surface due to the nature of the fractal model.
Proc. of SPIE Vol. 9689  96890Q-6
Downloaded From: http://proceedings.spiedigitallibrary.org/ on 06/21/2016 Terms of Use: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
0.0 0.1 0.2 0.3 0.4 0.5 0.6
Depth [cm]
0.0
0.5
1.0
1.5
2.0
No
rm
ali
se
d 
flu
en
ce
 ra
te
0.0 0.1 0.2 0.3 0.4 0.5 0.6
Depth [cm]
0.0
0.5
1.0
1.5
2.0
0.0 0.1 0.2 0.3 0.4 0.5 0.6
Depth [cm]
0.0
0.5
1.0
1.5
2.0
fractal
smooth
a b c
405 nm 540 nm 630 nm
Figure 6: Figure showing the fluence rate for three different wavelengths a) 405 nm, b) 540 nm and c) 630 nm.
For all three wavelengths the clustered model (solid) is compared to the equivalent smooth model (dashed).
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Figure 7: Figure showing the PDD for daylight PDT (during clear conditions) as well as conventional PDT
(Aktilite). The clustered model is compared to the equivalent smooth model. The figure demonstrates the
increase in effective treatment depth where the tumour density is redistributed according to figure 5.
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Figure 8: Image of the fluorescence light escaping from the tumour when illuminated with 405 nm light. The
intensity of the fluorescence light is normalised such that only the relative intensity is displayed in the image.
The tumour model described here is produced through a mathematical algorithm and will therefore not be
a true representation of tumour tissue. Even so, the added complexity shows the requirement of a 3D model
when studying light distribution through skin tissue where the distribution in all directions play an important
role. It has previously been suggested that two dimensional (2D) models are sufficient for representing the light
propagation, however the work presented here shows the importance of including a more complicated model.
Further developments of the model will include additional 3D tumour structures as well as a more detailed
representation of the healthy tissue surrounding the tumour.
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